GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Madrigal Pharmaceuticals Inc (STU:YDO1) » Definitions » FCF Yield %

Madrigal Pharmaceuticals (STU:YDO1) FCF Yield % : -8.03 (As of Apr. 28, 2024)


View and export this data going back to 2016. Start your Free Trial

What is Madrigal Pharmaceuticals FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Madrigal Pharmaceuticals's Trailing 12-Month Free Cash Flow is €-302.26 Mil, and Market Cap is €3,779.44 Mil. Therefore, Madrigal Pharmaceuticals's FCF Yield % for today is -8.03%.

The historical rank and industry rank for Madrigal Pharmaceuticals's FCF Yield % or its related term are showing as below:

STU:YDO1' s FCF Yield % Range Over the Past 10 Years
Min: -449.55   Med: -29.75   Max: -8.03
Current: -8.03


During the past 13 years, the highest FCF Yield % of Madrigal Pharmaceuticals was -8.03%. The lowest was -449.55%. And the median was -29.75%.

STU:YDO1's FCF Yield % is ranked better than
63.1% of 1550 companies
in the Biotechnology industry
Industry Median: -15.535 vs STU:YDO1: -8.03

Madrigal Pharmaceuticals's FCF Margin % for the quarter that ended in Dec. 2023 was 0.00%.


Madrigal Pharmaceuticals FCF Yield % Historical Data

The historical data trend for Madrigal Pharmaceuticals's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Madrigal Pharmaceuticals FCF Yield % Chart

Madrigal Pharmaceuticals Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
FCF Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.96 -9.50 -13.14 -4.35 -7.26

Madrigal Pharmaceuticals Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
FCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -4.52 -8.03 -7.11 -11.77 -7.22

Competitive Comparison of Madrigal Pharmaceuticals's FCF Yield %

For the Biotechnology subindustry, Madrigal Pharmaceuticals's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Madrigal Pharmaceuticals's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Madrigal Pharmaceuticals's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Madrigal Pharmaceuticals's FCF Yield % falls into.



Madrigal Pharmaceuticals FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Madrigal Pharmaceuticals's FCF Yield % for the fiscal year that ended in Dec. 2023 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=-298.675 / 4112.22026
=-7.26%

Madrigal Pharmaceuticals's annualized FCF Yield % for the quarter that ended in Dec. 2023 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=-74.249 * 4 / 4112.22026
=-7.22%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Madrigal Pharmaceuticals FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


Madrigal Pharmaceuticals FCF Yield % Related Terms

Thank you for viewing the detailed overview of Madrigal Pharmaceuticals's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Madrigal Pharmaceuticals (STU:YDO1) Business Description

Traded in Other Exchanges
Address
200 Barr Harbor Drive, Suite 200, Four Tower Bridge, West Conshohocken, PA, USA, 19428
Madrigal Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular-metabolic diseases and non-alcoholic steatohepatitis (NASH). The product portfolio of the company includes MGL-3196, an orally administered, small-molecule liver-directed B-selective THR agonist, which is used for the treatment of non-alcoholic steatohepatitis and familial hypercholesterolemia. Also, MGL-3196 reduces triglycerides in the plasma and liver by increasing fat metabolism and shows an anti-diabetic action.

Madrigal Pharmaceuticals (STU:YDO1) Headlines

No Headlines